Trial Profile
Switching from sulfonylurea to sitagliptin among type 2 diabetic patients in combination with metformin or pioglitazone.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Metformin; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 25 Jul 2012 New trial record